Dafne Quixabeira
MSc, Project Manager
Dafne Quixabeira has expertise in oncogenic viruses and in the development of cancer immunotherapies. Dafne is currently finishing her PhD at Cancer Gene Therapy Group (Finland), where she has evaluated the use of engineered oncolytic adenoviruses to enhance adoptive cell therapies and immune checkpoint blockade cancer treatments. Dafne is responsible for the internal and external project management, collaborations, and CMC activities.
